FibroGen (FGEN) BidaskScore is downgraded to Sold


The BidaskScore of FibroGen FGENFGEN shows that the shares of the company are now FGENStrongly Bought Sold by investors.

The BidaskScore of the BiotechnologyBiotechnology shows that the sector is BiotechnologyStrongly Bought Sold since March 26.

Here are the BidAskScore of other related companies in the Biotechnology sector:

FibroGenˌ Inc. operates as a science-based biopharmaceutical companyˌ which engages in the discoveryˌ developmentˌ and commercialization of therapeutics to treat unmet medical needs. It focuses on fibrosis and hypoxia-induced factor biology to generate programs targeting therapeutic areas. The company was founded by Thomas B. Neff on September 29ˌ 1993 and is headquartered in San Franciscoˌ CA.


Launched in 2016, the BidAskClubBidaskClub allows users to follow the evolution of the US equity market. BidaskClub provides a platform to create portfolios and be informed when a company´s or sector’s BidaskScore changes. BidaskClub is provided by LuxFinAdviceLuxFinAdvice.